Prelude Therapeutics Inc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD for Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Prelude Therapeutics Inc quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate for Q3 2024.
  • Prelude Therapeutics Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2024 was $3M.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.